There are 60 clinical trials listed on clinicaltrials.gov (accessed January 2022) for AZD1775 where it is being evaluated against a wide range of cancer types including breast cancer, cervical cancer, leukemia, lung cancer, ovarian cancer, pancreatic cancer, pediatric and adult brain tumors (For a list of completed and active clinical trials with Wee1 inhibitors, see Table 1). The gene discussed is WEE1; the disease is leukemia.